Mucoadhesive buccal films containing phospholipid-bile salts-mixed micelles as an effective carrier for Cucurbitacin B delivery

References

• Abruzzo A, Bigucci F, Cerchiara T, et al. (2012). Mucoadhesive chitosan/gelatin films for buccal delivery of propranolol hydrochloride. Carbohydr Polym 87:581–8
   PubMed Web of Science ®Google Scholar
• Agnihotri SA, Mallikarjuna NN, Aminabhavi TM. (2004). Recent advances on chitosan-based micro- and nanoparticles. J Control Release 100:5–28
   PubMed Web of Science ®Google Scholar
• Alkan-Onyuksel H, Ramakrishnan S, Chai HB, Pezzuto JM. (1994). A mixed micellar formulation suitable for the parenteral administration of taxol. Pharm Res 11:206–12
   PubMed Web of Science ®Google Scholar
• Allen C, Maysinger D, Eisenberg A. (1999). Nanoengineering block copolymer aggregates for drug delivery. Colloids Surf B Bio-interf 16:3–27
   Web of Science ®Google Scholar
• Amsalem O, Yuli-Amar I, Aserin A, Garti N. (2009). Phospholipids embedded fully dilutable liquid nanostructures. Part 1: compositions and solubilization capacity. Colloids Surf B Biointerfaces 73:15–22
   PubMed Web of Science ®Google Scholar
• Bajdik J, Marciello M, Caramella C, et al. (2009). Evaluation of surface and microstructure of differently plasticized chitosan films. J Pharm Biomed Anal 49:655–9
   PubMed Web of Science ®Google Scholar
• Bartalis J, Halaweish FT. (2005). Relationship between cucurbitacins reversed-phase high-performance liquid chromatography hydrophobicity index and basal cytotoxicity on HepG2 cells. J Chromatogr B Analyt Technol Biomed Life Sci 818:159–66
   PubMed Web of Science ®Google Scholar
• Boateng JS, Stevens HNE, Eccleston GM, et al. (2009). Development and mechanical characterization of solvent-cast polymeric films as potential drug delivery systems to mucosal surfaces. Drug Dev Ind Pharm 35:986–96
   PubMed Web of Science ®Google Scholar
• Di Colo G, Zambito Y, Zaino C. (2008). Polymeric enhancers of mucosal epithelia permeability: synthesis, transepithelial penetration-enhancing properties, mechanism of action, safety issues. J Pharm Sci 97:1652–80
   PubMed Web of Science ®Google Scholar
• Duan B, Sun P, Wang X, Yang C. (2013). Preparation and properties of starch nanocrystals/carboxymethyl chitosan nanocomposite films. Starch 63:528–35
   Web of Science ®Google Scholar
• El Zaafarany GM, Awad GA, Holayel SM, Mortada ND. (2010). Role of edge activators and surface charge in developing ultradeformable vesicles with enhanced skin delivery. Int J Pharm 397:164–72
   PubMed Web of Science ®Google Scholar
• Giovino C, Ayensu I, Tetteh J, Boateng JS. (2013). An integrated buccal delivery system combining chitosan films impregnated with peptide loaded PEG-b-PLA nanoparticles. Colloids Surf B Biointerfaces 112:9–15
   PubMed Web of Science ®Google Scholar
• Hammad MA, Müller BW. (1998). Increasing drug solubility by of bile salt-phosphatidylcholine-based mixed micelles. Eur J Pharm Biopharm 46:361–7
   PubMed Web of Science ®Google Scholar
• Hoogstraate AJ, Cullander C, Nagelkerke JF, et al. (1992). Diffusion rates and transport pathways of FITC-labelled model compounds through buccal epithelium. Pharma Res 11:83–9
   Google Scholar
• Hu H, Liu D, Zhao X, et al. (2013). Preparation, characterization, cellular uptake and evaluation in vivo of solid lipid nanoparticles loaded with cucurbitacin B. Drug Dev Ind Pharm 39:770–9
   PubMed Web of Science ®Google Scholar
• Jin S, Fu S, Han J, et al. (2012). Improvement of oral bioavailability of glycyrrhizin by sodium deoxycholate/phospholipid-mixed nanomicelles. J Drug Target 20:615–22
   PubMed Web of Science ®Google Scholar
• La SB, Okano T, Kataoka K. (1996). Preparation and characterization of the micelle-forming polymeric drug indomethacin-incorpo-rated poly(ethylene oxide)-poly(a-benzyl L-aspartate) block copolymer micelles. J Pharm Sci 85:85–90
   PubMed Web of Science ®Google Scholar
• Lee JH, Lee HB, Andrade JD. (1995). Blood compatibility of polyeth-ylene oxide surfaces. Prog Polym Sci 20:1043–79
   Web of Science ®Google Scholar
• Li CY, Hou SX, Yang K, Mao SJ. (2001). Study on quantitative determination of cucurbitacins B in plasma by HPLC. Chin Pharm J 36:557–9
   Google Scholar
• Luppi B, Bigucci F, Cerchiara T, Zecchi V. (2010). Chitosan-based hydrogels for nasal drug delivery: From inserts to nanoparticles. Expert Opin Drug Deliv 7:811–28
   PubMed Web of Science ®Google Scholar
• Lv QY, Li XY, Shen BD, et al. (2013). A solid phospholipid-bile salts-mixed micelles based on the fast dissolving oral films to improve the oral bioavailability of poorly water soluble drugs. J Nanopart Res (under review)
   Google Scholar
• Mazer NA, Benedek GB, Carey MC. (1980). Quasielastic light-scattering studies of aqueous biliary lipid systems. Mixed micelle formation in bile salt-lecithin solutions. Biochemistry 19:601–15
   PubMed Web of Science ®Google Scholar
• Molavi O, Ma Z, Mahmud A, et al. (2008). Polymeric micelles for the solubilization and delivery of STAT3 inhibitor cucurbitacins in solid tumors. Int J Pharm 347:118–27
   PubMed Web of Science ®Google Scholar
• Mosqueira VC, Legrand P, Gulik A, et al. (2001). Relationship between complement activation, cellular uptake and surface physicochemical aspects of novel PEG-modified nanocapsules. Biomaterials 22:2967–79
   PubMed Web of Science ®Google Scholar
• Navneet V, Pronobesh C. (2012). Preparation of mucoadhesive patches for buccal administration of metoprolol succinate: in vitro and in vivo drug release and bioadhesion. Trop J Pharma Res 11:9–17
   Web of Science ®Google Scholar
• Oh H, Mun YJ, Im SJ, et al. (2002). Cucurbitacins from Trichosanthes kirilowii as the inhibitory components on tyrosinase activity and melanin synthesis of B16/F10 melanoma cells. Planta Med 68:832–3
   PubMed Web of Science ®Google Scholar
• Park DM, Song YK, Jee JP, et al. (2012). Development of chitosan-based ondansetron buccal delivery system for the treatment of emesis. Drug Dev Ind Pharm 38:1077–83
   PubMed Web of Science ®Google Scholar
• Senel S, Kremer MJ, Kas S, et al. (2000). Enhancing effect of chitosan on peptide drug delivery across buccal mucosa. Biomaterials 21:2067–71
   PubMed Web of Science ®Google Scholar
• Tannin-Spitz T, Grossman S, Dovrat S, et al. (2007). Growth inhibitory activity of cucurbitacin glucosides isolated from Citrullus colocynthis on human breast cancer cells. Biochem Pharmacol 73:56–67
   PubMed Web of Science ®Google Scholar
• Ukiya M, Akihisa T, Yasukawa K, et al. (2002). Anti-inflammatory and anti-tumor-promoting effects of cucurbitane glycosides from the roots of Bryonia dioica. J Nat Prod 65:179–83
   PubMed Web of Science ®Google Scholar
• van der Lubben IM, Verhoef JC, Borchard G, Junginger HE. (2001). Chitosan and its derivatives in mucosal drug and vaccine delivery. Eur J Pharm Sci 14:201–7
   PubMed Web of Science ®Google Scholar
• Wang W, Zhao X, Hu H, et al. (2010). Galactosylated solid lipid nanoparticles with cucurbitacin B improves the liver targetability. Drug Deliv 17:114–22
   PubMed Web of Science ®Google Scholar
• Yang ZL, Li XR, Yang KW, Liu Y. (2008). Amphotericin B-loaded poly(ethylene glycol)-poly(lactide) micelles: Preparation, freeze–drying, and in vitro release. J Biomed Mater Res A 85A:539–46
   Web of Science ®Google Scholar
• Yu C, Han J, Yuan X, et al. (2013). Improved bioavailability and reduced adverse drug reaction of poorly soluble cucurbitacin B by sodium deoxycholate/phospholipid mixed micelles. J Biomed Nanotechnol (under review)
   Google Scholar